Abstract：Objective To investigate the clinical effect of terbutaline combined with Ipratropium Bromide in the treatment of chronic obstructive pulmonary disease (COPD).Methods A total of 153 patients with COPD admitted to our hospital from January 1,2017 to December 31,2018 were enrolled in this study.They were divided into reference group (75 cases) and observation group (78 cases) according to the parity grouping method.The reference group was treated with Terbutaline,the observation group was treated with Terbutaline combined with Ipratropium Bromide.The blood gas index,lung function index and clinical efficacy of the two groups of patients were analyzed and compared.Results After treatment,the levels of arterial oxygon sataration (SaO2) and arterial partial pressure of oxgyon (PaO2) in the observation group were higher than those in the reference group,and the level of arterial pantial pressure of carbon dvoxide (PaCO2) was lower than that in the reference group,the differences were statistically significant (P<0.05).The forced expiratory volume in the first second (FEV1),forced vital capacity (FEV1/FVC) and peak expiratony flow (PEF)levels in the observation group were higher than those in the reference group,the differences were statistically significant (P<0.05).The total effective rate of the observation group was 83.33% (65/78),which was higher than that of the reference group (50.67%),and the difference was statistically significant (P<0.05).Conclusion The clinical effect of Terbutaline combined with Ipratropium Bromide in the treatment of COPD is better,which can improve the blood gas index and lung function index of patients,and play a positive role in the stability of the disease.
京公网安备 11010502046607号